Old Web
English
Sign In
Acemap
>
authorDetail
>
Bryan K. Shipp
Bryan K. Shipp
Pfizer
Pharmaceutical manufacturing
Medicine
Toxicology
Health policy
Risk assessment
3
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.
2016
Regulatory Toxicology and Pharmacology
Eileen P. Hayes
Robert A. Jolly
Ellen C. Faria
Ester Lovsin Barle
Joel P. Bercu
Lance R. Molnar
Bruce D. Naumann
Michael J. Olson
Alison M. Pecquet
Reena Sandhu
Bryan K. Shipp
Robert G. Sussman
Patricia A. Weideman
Show All
Source
Cite
Save
Citations (15)
Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs)
2016
Regulatory Toxicology and Pharmacology
Joel P. Bercu
Eric Morinello
Claudia Sehner
Bryan K. Shipp
Patricia A. Weideman
Show All
Source
Cite
Save
Citations (25)
Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning.
2016
Regulatory Toxicology and Pharmacology
Michael J. Olson
Ellen C. Faria
Eileen P. Hayes
Robert A. Jolly
Ester Lovsin Barle
Lance R. Molnar
Bruce D. Naumann
Alison M. Pecquet
Bryan K. Shipp
Robert G. Sussman
Patricia A. Weideman
Show All
Source
Cite
Save
Citations (5)
1